Stabilise membrane proteins
Tuesday, 16 September, 2008
The new MembraneMax Protein Expression Kits allow researchers to rapidly produce milligrams of soluble membrane proteins that are exceptionally easy to purify. Over 50 per cent of targets in pharmaceutical drug development are membrane proteins. The MembraneMax technology uses nanolipoprotein disks to capture, fold and stabilise membrane proteins produced in a cell-free protein expression system. In initial performance testing, over 30 human membrane proteins were expressed at >0.1mg/ml in soluble form using the new kits. MembraneMax Protein Expression Kits will be a welcome addition to the tools available to membrane protein researchers struggling to understand the detailed molecular structure and function of this therapeutically important class of proteins. Invitrogen Tel: 1800 331 627 www.invitrogen.com/membranemax
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
Gene therapy slows Huntington's disease progression in trial
Patients receiving the treatment were found to experience 75% less progression of the disease...
